Report Company Directory

Zellidja S.A.

• Monthly LMI Update Independent Investment Research by Independent Investment Research
• Ford Equity International Rating and Forecast Report by Ford Equity Research

ZELLUNA ASA

• Zelluna ASA - Grant of Share Options by GlobeNewsWire
• Zelluna ASA: Invitation to Fourth Quarter 2025 Results Webcast Presentation by GlobeNewsWire
• Zelluna utnevner Emilie Gauthy til Chief Technology Officer by GlobeNewsWire
• Zelluna promotes Emilie Gauthy to Chief Technology Officer by GlobeNewsWire
• Zelluna ASA: Approval and publication of prospectus by GlobeNewsWire
• Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer. by GlobeNewsWire
• Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours by GlobeNewsWire
• Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours by GlobeNewsWire
• Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial by GlobeNewsWire
• Zelluna ASA: Cancellation of subsequent repair offering by GlobeNewsWire

ZELTIQ Aesthetics Inc

• INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders by BusinessWire
• ZELTIQ AESTHETICS (ZLTQ) SHAREHOLDER ALERT – Andrews & Springer LLC is Investigating ZELTIQ Aesthetics, Inc. for Potential Breaches of Fiduciary Duty by BusinessWire
• INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZELTIQ Aesthetics, Inc. And Encourages Shareholders To Contact The Firm For Additional Information by BusinessWire
• ZELTIQ AESTHETICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Allergan plc May be Unfair to Shareholders by BusinessWire
• SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZELTIQ Aesthetics, Inc. And Encourages Investors To Contact The Firm For Additional Information by BusinessWire

Zemaitijos Pienas AB

• AB "ŽEMAITIJOS PIENAS" – nekilnojamojo turto pardavimas by GlobeNewsWire
• ŽEMAITIJOS PIENAS, AB – Sale of Real Estate by GlobeNewsWire
• ŽEMAITIJOS PIENAS įsigis savų akcijų by GlobeNewsWire
• ŽEMAITIJOS PIENAS will buy-back its own shares by GlobeNewsWire
• Dėl savų akcijų supirkimo by GlobeNewsWire
• Regarding the Acquisition of Own Shares by GlobeNewsWire
• AB "ŽEMAITIJOS PIENAS" grupės 2025 m. I pusmečio informacija by GlobeNewsWire
• ŽEMAITIJOS PIENAS AB Group half-year information for the I-st half of 2025 by GlobeNewsWire
• Preliminarus AB “ŽEMAITIJOS PIENAS“ grupės 2025 m. I pusmečio rezultatas by GlobeNewsWire
• Preliminary results of ŽEMAITIJOS PIENAS AB group for the first half of 2025 by GlobeNewsWire

ZEMELNIY FOND SOLID PODMOSKOVNIY